Clinical Trial Update: Study Evaluating Management of Patients With Moderate and Severe Psoriasis

View source ↗

Summary

A clinical trial evaluating management of patients with moderate to severe psoriasis has completed; Wyeth is now a wholly owned subsidiary of Pfizer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Snippet

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Psoriasis | Status: COMPLETED